RAPT Therapeutics (RAPT) Gains from Investment Securities (2020 - 2024)
Historic Gains from Investment Securities for Therapeutics (RAPT) over the last 5 years, with Q3 2024 value amounting to $5.2 million.
- Therapeutics' Gains from Investment Securities changed N/A to $5.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.2 million, marking a year-over-year increase of 25298.51%. This contributed to the annual value of $100000.0 for FY2024, which is 8571.43% down from last year.
- Latest data reveals that Therapeutics reported Gains from Investment Securities of $5.2 million as of Q3 2024.
- Over the past 5 years, Therapeutics' Gains from Investment Securities peaked at $6.6 million during Q1 2022, and registered a low of $700000.0 during Q4 2023.
- For the 5-year period, Therapeutics' Gains from Investment Securities averaged around $3.2 million, with its median value being $2.6 million (2020).
- Its Gains from Investment Securities has fluctuated over the past 5 years, first surged by 7471.42% in 2021, then plummeted by 5263.87% in 2023.
- Over the past 5 years, Therapeutics' Gains from Investment Securities (Quarter) stood at $2.4 million in 2020, then changed by 0.0% to $2.4 million in 2021, then crashed by 38.42% to $1.5 million in 2022, then tumbled by 52.64% to $700000.0 in 2023, then soared by 645.3% to $5.2 million in 2024.
- Its Gains from Investment Securities was $5.2 million in Q3 2024, compared to $5.6 million in Q2 2024 and $5.5 million in Q1 2024.